Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients
Titel:
Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients
Auteur:
Kaduthanam, Sajo Gade, Stephan Meister, Michael Brase, Jan C. Johannes, Marc Dienemann, Hendrik Warth, Arne Schnabel, Philipp A. Herth, Felix J.F. Sültmann, Holger Muley, Thomas Kuner, Ruprecht